Open AccessTreatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
Author(s) -
Roland Chapurlat
Publication year - 2009
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s3768
Subject(s) - zoledronic acid , medicine , hip fracture , osteoporosis , placebo , randomized controlled trial , incidence (geometry) , surgery , alternative medicine , pathology , physics , optics
Several treatments for postmenopausal osteoporosis have been available in the past decade, but adherence to these treatments has been judged inadequate. The prevention of hip fracture by these medications is still modest.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom